Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding

被引:95
作者
Le Gall, F
Kipriyanov, SM
Moldenhauer, G
Little, M
机构
[1] Deutsch Krebsforschungszentrum, Recombitant Antibody Res Grp D0500, D-69120 Heidelberg, Germany
[2] Deutsch Krebsforschungszentrum, Dept Mol Immunol, D-69120 Heidelberg, Germany
关键词
single chain Fv; diabody; triabody; tetrabody; human CD19;
D O I
10.1016/S0014-5793(99)00713-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Single chain variable fragments (scFv) of the murine monoclonal antibody HD37 specific to human B-cell antigen CD19 were constructed by joining the V-H and V-L domains with linkers of 18, 10, 1 and 0 residues, ScFv-18 formed monomers, dimers and small amounts of tetramers; scFv-10 formed dimers and small amounts of tetramers; scFv-1 formed exclusively tetramers; scFv-0 formed exclusively trimers, The affinities of the scFv-10 (diabody) and scFv-1 (tetrabody) were approximately 1.5- and 2.5-fold higher, respectively, than that of the scFv-0 (triabody). The tetrabody displayed a significantly prolonged association with cell-bound antigen (t(1/2) cell surface retention at 37 degrees C of 26.6 min) compared to both the diabody (13.3 min) and triabody (6.7 min). This increase in avidity of the tetrabody combined with its larger size could prove to be particularly advantageous for imaging and the immunotherapy of B-cell malignancies, (C) 1999 Federation of European Biochemical Societies.
引用
收藏
页码:164 / 168
页数:5
相关论文
共 23 条
[1]  
ADAMS GP, 1993, CANCER RES, V53, P4026
[2]   Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu [J].
Adams, GP ;
Schier, R ;
McCall, AM ;
Crawford, RS ;
Wolf, EJ ;
Weiner, LM ;
Marks, JD .
BRITISH JOURNAL OF CANCER, 1998, 77 (09) :1405-1412
[3]   Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment [J].
Arndt, KM ;
Müller, KM ;
Plückthun, A .
BIOCHEMISTRY, 1998, 37 (37) :12918-12926
[4]   SINGLE-CHAIN ANTIGEN-BINDING PROTEINS [J].
BIRD, RE ;
HARDMAN, KD ;
JACOBSON, JW ;
JOHNSON, S ;
KAUFMAN, BM ;
LEE, SM ;
LEE, T ;
POPE, SH ;
RIORDAN, GS ;
WHITLOW, M .
SCIENCE, 1988, 242 (4877) :423-426
[5]   DIABODIES - SMALL BIVALENT AND BISPECIFIC ANTIBODY FRAGMENTS [J].
HOLLIGER, P ;
PROSPERO, T ;
WINTER, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) :6444-6448
[6]   PROTEIN ENGINEERING OF ANTIBODY-BINDING SITES - RECOVERY OF SPECIFIC ACTIVITY IN AN ANTI-DIGOXIN SINGLE-CHAIN FV ANALOG PRODUCED IN ESCHERICHIA-COLI [J].
HUSTON, JS ;
LEVINSON, D ;
MUDGETTHUNTER, M ;
TAI, MS ;
NOVOTNY, J ;
MARGOLIES, MN ;
RIDGE, RJ ;
BRUCCOLERI, RE ;
HABER, E ;
CREA, R ;
OPPERMANN, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) :5879-5883
[7]   Triabodies: Single chain Fv fragments without a linker form trivalent trimers [J].
Iliades, P ;
Kortt, AA ;
Hudson, PJ .
FEBS LETTERS, 1997, 409 (03) :437-441
[8]  
KABAT EA, 1991, PUBLIC HLTH SERV
[9]   High level production of soluble single chain antibodies in small-scale Escherichia coli cultures [J].
Kipriyanov, SM ;
Moldenhauer, G ;
Little, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 1997, 200 (1-2) :69-77
[10]  
Kipriyanov SM, 1998, INT J CANCER, V77, P763, DOI 10.1002/(SICI)1097-0215(19980831)77:5<763::AID-IJC16>3.0.CO